MSF Field Research >
1 Published Research and Commentary >
Ambulatory Multi-Drug Resistant Tuberculosis Treatment Outcomes in a Cohort of HIV-Infected Patients in a Slum Setting in Mumbai, India.
this identifier to cite or link
to this item:
|Download this article:|
|Isaakidis MDR TB in Mumbai PLoS One.pdf||210Kb||Adobe PDF|
|Title: ||Ambulatory Multi-Drug Resistant Tuberculosis Treatment Outcomes in a Cohort of HIV-Infected Patients in a Slum Setting in Mumbai, India.|
|Affiliation: ||Médecins Sans Frontières, Mumbai, India.|
|Citation: ||Ambulatory Multi-Drug Resistant Tuberculosis Treatment Outcomes in a Cohort of HIV-Infected Patients in a Slum Setting in Mumbai, India. 2011, 6 (12):e28066 PLoS ONE|
|Journal: ||PloS One|
|Issue Date: ||Dec-2011 |
|PubMed ID: ||22145022|
|Abstract: ||India carries one quarter of the global burden of multi-drug resistant TB (MDR-TB) and has an estimated 2.5 million people living with HIV. Despite this reality, provision of treatment for MDR-TB is extremely limited, particularly for HIV-infected individuals. Médecins Sans Frontières (MSF) has been treating HIV-infected MDR-TB patients in Mumbai since May 2007. This is the first report of treatment outcomes among HIV-infected MDR-TB patients in India.|
|Rights: ||Published by Public Library of Science, http://www.plosone.org/
Archived on this site by Open Access permission|
|Appears in topics: ||TB|
|Related articles on PubMed|
Adverse events among HIV/MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, India.
Isaakidis P, Varghese B, Mansoor H, Cox HS, Ladomirska J, Saranchuk P, Da Silva E, Khan S, Paryani R, Udwadia Z, Migliori GB, Sotgiu G, Reid T
|See all 259 articles|
All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.